# Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC

> **NCT00291850** · PHASE2 · TERMINATED · sponsor: **Central European Cooperative Oncology Group** · enrollment: 50 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** Paclitaxel, Cisplatin, Pegfilgrastim

## Key facts

- **NCT ID:** NCT00291850
- **Lead sponsor:** Central European Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** no patient recruitment
- **Last updated:** 2012-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00291850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00291850, "Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00291850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*